TKL Research Builds New Phase I Research Facility in NJ

TKL Research Builds New Phase I Research Facility in NJ

Related tags Medicine New jersey

CRO TKL Research is constructing a new clinical research facility that will include a 30-bed, Phase I unit as well as multiple, outpatient clinical examination rooms. 

The new Fair Lawn, New Jersey-based facility, which will expand the company’s capabilities to conduct a range of dermatological safety studies, will join three other TKL Research clinics in northern New Jersey. The company also has expertise in gastroenterology, respiratory, endocrinology and women’s health.

Reid Tripp, VP of business development, told us that the “addition of the new facility is based on increase client demand​” in Phase I clinical trials.

The company also offers clinical trial management services, from strategy and protocol development to biostatistics, medical writing and regulatory submission.

TKL in 2006 moved its CRO operations to Rochelle Park, New Jersey, and later expanded its European capabilities with clinical operations in Münster, Germany, in 2010. 

Related topics Clinical Development Phase I-II

Related news

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Related suppliers